cefuroxime has been researched along with Bacteremia in 34 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our objective was to examine whether empirical antimicrobial therapy (EAT) against methicillin-susceptible Staphylococcus aureus bacteremia (MS-SAB) with piperacillin-tazobactam (TZP), cefuroxime or combination therapy with one of these was differentially associated with 7-, 30-, and 90- day all-cause mortality or MS-SAB relapse." | 8.12 | Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia. ( Benfield, T; Bigseth, RS; Petersen, A; Sandholdt, H; Thorlacius-Ussing, L; Østergaard, C, 2022) |
| "Our objective was to examine whether empirical antimicrobial therapy (EAT) against methicillin-susceptible Staphylococcus aureus bacteremia (MS-SAB) with piperacillin-tazobactam (TZP), cefuroxime or combination therapy with one of these was differentially associated with 7-, 30-, and 90- day all-cause mortality or MS-SAB relapse." | 4.12 | Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia. ( Benfield, T; Bigseth, RS; Petersen, A; Sandholdt, H; Thorlacius-Ussing, L; Østergaard, C, 2022) |
| "Our results suggest that, after susceptibility testing, cefuroxime or aminopenicillins are preferable to benzylpenicillins as definitive therapy for Haemophilus bacteremia." | 3.78 | Treatment of Haemophilus bacteremia with benzylpenicillin is associated with increased (30-day) mortality. ( Thønnings, S; Østergaard, C, 2012) |
| " We report a toddler who had breakthrough bacteremia and meningitis develop because of drug-resistant pneumococcus while receiving treatment with cefotaxime and cefuroxime for pneumonia." | 3.70 | Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. ( Brown, SP; Buckingham, SC; Joaquin, VH, 1998) |
| "In addition, septic shock occurred in 6 cases (2." | 2.73 | Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime. ( Falagas, M; Falagas, ME; Geroulanos, S; Karatza, D; Kriaras, I; Mastoraki, E; Michalopoulos, A; Mouchtouri, E, 2008) |
| "Also for lower respiratory tract infections (LTRI) the clinical and bacteriological responses were quite similar, although relatively more failures occurred in CF treated patients with LRTI caused by pneumococci." | 2.67 | Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety. ( Andersen, BM; Bergan, T; Brubakk, O; Bruun, JN; Døskeland, B; Hellum, KB; Hopen, G; Kalager, T; Rahm, V; von der Lippe, E, 1992) |
| "Standard once-daily dosing of ceftriaxone may not lead to adequate antibiotic exposure in all cases of Staphylococcus aureus bacteraemia (SAB)." | 1.91 | Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study. ( Bonten, MJM; Buis, DTP; Herpers, BL; Jansen, RR; Prins, JM; Rozemeijer, W; Sieswerda, E; Sigaloff, KCE; Soetekouw, R; van der Meer, JTM; van der Vaart, TW; van Twillert, G; van Werkhoven, CH; Veenstra, J, 2023) |
| "Cefuroxime was the initial empiric antimicrobial agent given for 66/76 of the patients and treatment outcome was favorable for 20/22 patients who received cefuroxime at least up to day 5." | 1.72 | Clinical and microbiological characterization of Aerococcus urinae bacteraemias at Helsinki metropolitan area, Finland. ( Grönroos, JO; Lehtola, L; Pakarinen, L; Pätäri-Sampo, A; Rantakokko-Jalava, K; Sihvonen, R; Turunen, M, 2022) |
| "G." | 1.48 | Bacteramia Caused by Gardnerella Vaginalis in a Cesarean Section Patient. ( Chen, Y; Guo, P; Han, X; Huang, H; Liao, K; Wu, Z, 2018) |
| "All animals developed severe sepsis/septic shock." | 1.40 | Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model. ( Castegren, M; Jonsson, AB; Larsson, A; Lipcsey, M; Maudsdotter, L; Sjölin, J; Skorup, P, 2014) |
| "Despite the clinical significance of Salmonella infections, surveillance data worldwide remains limited and is more so exemplified by the lack of reports from Africa especially in eastern, central and western Africa." | 1.40 | Salmonella blood stream infections in a tertiary care setting in Ghana. ( Addison, NO; Donkor, ES; Labi, AK; Obeng-Nkrumah, N, 2014) |
| "Paraspinal abscess and spondylodiscitis due to Citrobacter koseri is a very rare condition." | 1.38 | Citrobacter koseri bacteraemia complicated by paraspinal abscess and spondylodiscitis--a case report. ( Hayati, SN; Kumar, CS; Lee, C; Leong, CL, 2012) |
| "Infants and children with pneumococcal infections cared for at eight children's hospitals." | 1.31 | Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. ( Barson, WJ; Bradley, JS; Givner, LB; Kaplan, SL; Kim, KS; Mason, EO; Schutze, GE; Tan, TQ; Wald, ER; Yogev, R, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (41.18) | 18.2507 |
| 2000's | 6 (17.65) | 29.6817 |
| 2010's | 11 (32.35) | 24.3611 |
| 2020's | 3 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Sihvonen, R | 1 |
| Turunen, M | 1 |
| Lehtola, L | 1 |
| Pakarinen, L | 1 |
| Grönroos, JO | 1 |
| Rantakokko-Jalava, K | 1 |
| Pätäri-Sampo, A | 1 |
| Bigseth, RS | 1 |
| Sandholdt, H | 1 |
| Petersen, A | 1 |
| Østergaard, C | 2 |
| Benfield, T | 3 |
| Thorlacius-Ussing, L | 1 |
| Buis, DTP | 1 |
| van der Vaart, TW | 1 |
| Prins, JM | 1 |
| van der Meer, JTM | 1 |
| Bonten, MJM | 1 |
| Sieswerda, E | 1 |
| van Werkhoven, CH | 1 |
| Sigaloff, KCE | 1 |
| Herpers, BL | 1 |
| Jansen, RR | 1 |
| Rozemeijer, W | 1 |
| Soetekouw, R | 1 |
| van Twillert, G | 1 |
| Veenstra, J | 1 |
| Chen, Y | 1 |
| Han, X | 1 |
| Guo, P | 1 |
| Huang, H | 1 |
| Wu, Z | 1 |
| Liao, K | 1 |
| Nissen, JL | 1 |
| Skov, R | 1 |
| Knudsen, JD | 2 |
| Ostergaard, C | 2 |
| Schønheyder, HC | 2 |
| Frimodt-Møller, N | 1 |
| Crane, JK | 1 |
| Rasmussen, JB | 1 |
| Arpi, M | 1 |
| van der Vusse, ML | 1 |
| van Son, WJ | 1 |
| Ott, A | 1 |
| Manson, W | 1 |
| Skorup, P | 1 |
| Maudsdotter, L | 1 |
| Lipcsey, M | 1 |
| Castegren, M | 1 |
| Larsson, A | 1 |
| Jonsson, AB | 1 |
| Sjölin, J | 1 |
| Labi, AK | 1 |
| Obeng-Nkrumah, N | 1 |
| Addison, NO | 1 |
| Donkor, ES | 2 |
| Bremmer, DN | 1 |
| Balada-Llasat, JM | 1 |
| Goff, DA | 1 |
| Bauer, KA | 1 |
| Melendez, J | 1 |
| Claxton, A | 1 |
| Erskine, K | 1 |
| Thønnings, S | 1 |
| Hayati, SN | 1 |
| Leong, CL | 1 |
| Kumar, CS | 1 |
| Lee, C | 1 |
| Otermin, I | 1 |
| Lai, CH | 1 |
| Hwang, CK | 1 |
| Chin, C | 1 |
| Lin, HH | 1 |
| Wong, WW | 1 |
| Liu, CY | 1 |
| Kariuki, S | 1 |
| Revathi, G | 1 |
| Kariuki, N | 1 |
| Kiiru, J | 1 |
| Mwituria, J | 1 |
| Hart, CA | 1 |
| Mastoraki, E | 1 |
| Michalopoulos, A | 1 |
| Kriaras, I | 1 |
| Mouchtouri, E | 1 |
| Falagas, ME | 1 |
| Falagas, M | 1 |
| Karatza, D | 1 |
| Geroulanos, S | 1 |
| Amyes, SG | 1 |
| Baird, DR | 1 |
| Crook, DW | 1 |
| Gillespie, SH | 1 |
| Howard, AJ | 1 |
| Oppenhiem, BA | 1 |
| Pedler, SJ | 1 |
| Paull, A | 1 |
| Tompkins, DS | 1 |
| Lawrie, SA | 1 |
| Arstila, T | 1 |
| Auvinen, H | 1 |
| Huovinen, P | 1 |
| Patrick, CC | 1 |
| Furuta, GT | 1 |
| Edwards, M | 1 |
| Estabrook, M | 1 |
| Blake, MS | 1 |
| Baker, CJ | 1 |
| Krause, I | 1 |
| Nimri, R | 1 |
| Domínguez, H | 1 |
| Vogel, BF | 1 |
| Gram, L | 1 |
| Hoffmann, S | 1 |
| Schaebel, S | 1 |
| Nohara, T | 1 |
| Kobayashi, I | 1 |
| Mathur, YC | 1 |
| Mathur, NC | 1 |
| Lal, HM | 1 |
| Levi, N | 1 |
| Eiberg, J | 1 |
| Skov Jensen, J | 1 |
| Prag, J | 1 |
| Jørgensen, J | 1 |
| Schroeder, TV | 1 |
| Buckingham, SC | 1 |
| Brown, SP | 1 |
| Joaquin, VH | 1 |
| Wahlmann, U | 1 |
| Al-Nawas, B | 1 |
| Jütte, M | 1 |
| Wagner, W | 1 |
| Arnez, M | 1 |
| Ruzić-Sabljić, E | 1 |
| Ahcan, J | 1 |
| Radsel-Medvescek, A | 1 |
| Pleterski-Rigler, D | 1 |
| Strle, F | 1 |
| Kaplan, SL | 1 |
| Mason, EO | 1 |
| Barson, WJ | 1 |
| Tan, TQ | 1 |
| Schutze, GE | 1 |
| Bradley, JS | 1 |
| Givner, LB | 1 |
| Kim, KS | 1 |
| Yogev, R | 1 |
| Wald, ER | 1 |
| Katoh, H | 1 |
| Singh, KP | 1 |
| Voolmann, T | 1 |
| Lang, SD | 1 |
| Kalager, T | 1 |
| Andersen, BM | 1 |
| Bergan, T | 1 |
| Brubakk, O | 1 |
| Bruun, JN | 1 |
| Døskeland, B | 1 |
| Hellum, KB | 1 |
| Hopen, G | 1 |
| von der Lippe, E | 1 |
| Rahm, V | 1 |
| Biermann, H | 1 |
| Rick, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Randomised Controlled Trial of Penicillin Versus Flucloxacillin for Definitive Treatment of Invasive Penicillin Susceptible Staphylococcus Aureus[NCT03632642] | Phase 4 | 0 participants (Actual) | Interventional | 2019-07-01 | Withdrawn (stopped due to Study never commenced) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for cefuroxime and Bacteremia
| Article | Year |
|---|---|
Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefuroxime; Coronary Artery Bypass; Drug | 2008 |
Clinical and microbiological efficacy of single dose cefuroxime prophylaxis for dental surgical procedures.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Cefuroxime; Dentistry, Operative; Drug Administration Sc | 1999 |
Incidence of transient bacteremia following dental surgery--prophylactic use of cefuroxime, ceftriaxone or clindamycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Cefuroxime; Clindamycin; Dentistry, Ope | 1992 |
Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety.
Topics: Adult; Aged; Bacteremia; Cefuroxime; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; | 1992 |
30 other studies available for cefuroxime and Bacteremia
| Article | Year |
|---|---|
Clinical and microbiological characterization of Aerococcus urinae bacteraemias at Helsinki metropolitan area, Finland.
Topics: Aerococcus; Aged; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Cefuroxime; Disease Susceptibility | 2022 |
Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Cohort Studies; Humans; Methicillin; Piperacil | 2022 |
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ceftriaxone; Cefuroxime; Floxacillin; Humans | 2023 |
Bacteramia Caused by Gardnerella Vaginalis in a Cesarean Section Patient.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Cesarean Section; Female; Gardnerella vaginali | 2018 |
Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; | 2013 |
Resurgence of penicillin-susceptible Staphylococcus aureus at a hospital in New York State, USA.
Topics: Anti-Bacterial Agents; Bacteremia; Cefuroxime; Dicloxacillin; Female; Humans; Male; Penicillins; Sta | 2014 |
Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Cohort Studies; Dicloxacilli | 2014 |
Helicobacter canis bacteremia in a renal transplant patient.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Ciprofloxacin; DNA, Bacterial; DNA, Ribosomal; | 2014 |
Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Load; Cefuroxime; Critical Care; Disease Model | 2014 |
Salmonella blood stream infections in a tertiary care setting in Ghana.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Child; Child, Preschool; Dis | 2014 |
Ceftriaxone Etest non-susceptible methicillin susceptible Staphylococcus aureus time-kill responses.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Ceftaroline; Ceftriaxone; Cefuroxime; Cephalosporins; C | 2017 |
MRSA bacteraemia after caesarean section wound infection: when screening is missed and things go wrong.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefuroxime; Cesarean Sec | 2012 |
Treatment of Haemophilus bacteremia with benzylpenicillin is associated with increased (30-day) mortality.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Child; Denmark; Disk Diffusion Antimicrobial Te | 2012 |
Citrobacter koseri bacteraemia complicated by paraspinal abscess and spondylodiscitis--a case report.
Topics: Abscess; Aged; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Citrobacter koseri; Discitis; Enteroba | 2012 |
[SEIMC protocol on osteoarticular and soft tissue infection, and asymptomatic bacteriuria: value of extended prophylaxis].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacteriuria; Bone Diseases, Infectious; C | 2003 |
Severe watery diarrhoea and bacteraemia caused by Vibrio fluvialis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Diarrhea; Drug Resistance, Multiple, Bacterial; | 2006 |
Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya.
Topics: Bacteremia; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Community-Acquired Infections; Diarrhe | 2006 |
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Bacteriuria; Cefotaxime; Ceftazidime; Cefuroxime; Cepha | 1994 |
Beta-lactam resistance among Escherichia coli and Klebsiella species blood culture isolates in Finnish hospitals. Finnish Study Group for Antimicrobial Resistance.
Topics: Bacteremia; beta-Lactam Resistance; Cefuroxime; Cephalosporins; Drug Utilization; Escherichia coli; | 1994 |
Variation in phenotypic expression of the Opa outer membrane protein and lipooligosaccharide of Neisseria meningitidis serogroup C causing periorbital cellulitis and bacteremia.
Topics: Antigens, Bacterial; Bacteremia; Bacterial Outer Membrane Proteins; Cefuroxime; Cellulitis; Electrop | 1993 |
Kingella kingae occult bacteremia in a toddler.
Topics: Age Factors; Bacteremia; Cefuroxime; Cephalosporins; Child, Preschool; Female; Humans; Kingella king | 1996 |
Shewanella alga bacteremia in two patients with lower leg ulcers.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Female; Gentamic | 1996 |
Transient bacteremia after tooth extraction with intravenous cefuroxime prophylaxis.
Topics: Adult; Aged; Bacteremia; Cefuroxime; Cephalosporins; Female; Humans; Injections, Intravenous; Male; | 1995 |
Clinical efficacy of Cefuroxime axetil in S. typhi.
Topics: Bacteremia; Cefuroxime; Cephalosporins; Child; Female; Follow-Up Studies; Humans; Male; Prodrugs; Re | 1996 |
Mycoplasma in urine and blood following catheterisation of patients undergoing vascular surgery.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Bacteremia; Bacteriuria; Cefuroxime; Cephalo | 1997 |
Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia.
Topics: Bacteremia; Cefotaxime; Cefuroxime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multi | 1998 |
Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans.
Topics: Bacteremia; Bacteriological Techniques; Borrelia burgdorferi Group; Cefuroxime; Cephalosporins; Chil | 2001 |
Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporin Resistance; Ce | 2001 |
Pneumococcal bacteraemia in south Auckland: a five year review with emphasis on prescribing practices.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacteremia; Cefuroxi | 1992 |
[Comparative studies of preventive antibiotic administration in ERCP].
Topics: Aged; Aged, 80 and over; Ampulla of Vater; Bacteremia; Cefuroxime; Cholangiopancreatography, Endosco | 1992 |